AEON Biopharma宣布，公司已顺利完成与美国食品药品监督管理局（FDA）就B型2a期临床试验举行的专题会议，并就11月达成的相关交易事项获得股东正式批准。
AEON Biopharma宣布，公司已顺利完成与美国食品药品监督管理局（FDA）就B型2a期临床试验举行的专题会议，并就11月达成的相关交易事项获得股东正式批准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.